✦ LIBER ✦

The Current Role of Angiogenesis Inhibitors in the Treatment of Renal Cell Carcinoma

✍ Scribed by Toni K. Choueiri; Ronald M. Bukowski; Brian I. Rini

Book ID: 114473972
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 627 KB
Volume: 33
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2006.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis in renal cell carcinoma: Th

Angiogenesis in renal cell carcinoma: The role of tumor-associated macrophages

✍ Hiroshi Toge; Takeshi Inagaki; Yasuo Kojimoto; Toshiaki Shinka; Isao Hara 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Renal cell carcinoma: rationale and deve

Renal cell carcinoma: rationale and development of therapeutic inhibitors of angiogenesis

✍ Ebbinghaus, Scot W.; Gordon, Michael S. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Role of lymphadenectomy in the treatment

Role of lymphadenectomy in the treatment of renal cell carcinoma

✍ Emilia Phillips; Edward M. Messing 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 935 KB

PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR

PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN IRELAND

✍ R. McDermott; P. Donnellan; J. McCaffery; F. Keane; S.P. Sarda; C. Korves; A. Lu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Current Perspectives in Metastatic Renal

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Mammalian Target of Rapamycin (mTOR) Inhibition

✍ Sergio Bracarda; Jean-Jacques Patard; Alain Ravaud 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Role of immunotherapy in the treatment o

Role of immunotherapy in the treatment of bladder and renal cell carcinoma

✍ Nelson N. Stone; Michael J. Droller 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Much remains to be learned about the immune response in human neoplasia both in a phenomenological sense and in its therapeutic possibilities. Recruitment of immune response mechanisms in the defense against cancer development and in the cure of advanced disease, though theoretically sound, remains